CHRISTINE ROBINET: Open Payments
NPI 1679040844 · LENOX, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,912 in 106 payments from 23 companies in 2025. Trend: 2023 $790 · 2024 $1,875 · 2025 $1,912
Food & beverage: $1,912
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $227 |
| ABBVIE INC. | 13 | $210 |
| Otsuka America Pharmaceutical, Inc. | 8 | $193 |
| Novo Nordisk Inc | 11 | $179 |
| Lilly USA, LLC | 12 | $163 |
| PFIZER INC. | 8 | $161 |
| Exact Sciences Corporation | 6 | $107 |
| Amgen Inc. | 7 | $103 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87 |
Products named: REXULTI, NURTEC ODT, FARXIGA, VRAYLAR, The Cologuard Plus Collection Kit, MOUNJARO, JARDIANCE, BREZTRI.
Industry payments across MI — which companies pay providers there.
